AJP - GI Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 296: G735-G739, 2009. First published February 12, 2009; doi:10.1152/ajpgi.90708.2008
0193-1857/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/4/G735    most recent
90708.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, J.
Right arrow Articles by Rayner, C. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, J.
Right arrow Articles by Rayner, C. K.

HORMONES AND SIGNALING

Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects

Jing Ma,1,4 Max Bellon,2 Judith M. Wishart,1,4 Richard Young,1,3,4 L. Ashley Blackshaw,1,3,4 Karen L. Jones,1,4 Michael Horowitz,1,4 and Christopher K. Rayner1,4

Royal Adelaide Hospital, 1University of Adelaide, Discipline of Medicine, 2Department of Nuclear Medicine, PET and Bone Densitometry, 3Nerve Gut Laboratory, Hanson Institute; 4Centre of Clinical Research Excellence in Nutritional Physiology, Interventions and Outcomes, University of Adelaide, Adelaide, Australia

Submitted 18 December 2008 ; accepted in final form 6 February 2009

The incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), play an important role in glucose homeostasis in both health and diabetes. In mice, sucralose, an artificial sweetener, stimulates GLP-1 release via sweet taste receptors on enteroendocrine cells. We studied blood glucose, plasma levels of insulin, GLP-1, and GIP, and gastric emptying (by a breath test) in 7 healthy humans after intragastric infusions of 1) 50 g sucrose in water to a total volume of 500 ml (~290 mosmol/l), 2) 80 mg sucralose in 500 ml normal saline (~300 mosmol/l, 0.4 mM sucralose), 3) 800 mg sucralose in 500 ml normal saline (~300 mosmol/l, 4 mM sucralose), and 4) 500 ml normal saline (~300 mosmol/l), all labeled with 150 mg 13C-acetate. Blood glucose increased only in response to sucrose (P < 0.05). GLP-1, GIP, and insulin also increased after sucrose (P = 0.0001) but not after either load of sucralose or saline. Gastric emptying of sucrose was slower than that of saline (t50: 87.4 ± 4.1 min vs. 74.7 ± 3.2 min, P < 0.005), whereas there were no differences in t50 between sucralose 0.4 mM (73.7 ± 3.1 min) or 4 mM (76.7 ± 3.1 min) and saline. We conclude that sucralose, delivered by intragastric infusion, does not stimulate insulin, GLP-1, or GIP release or slow gastric emptying in healthy humans.



Address for reprint requests and other correspondence: C. K. Rayner, Disc. of Medicine, Royal Adelaide Hosp., North Terr., Adelaide SA 5000, Australia (e-mail: chris.rayner{at}adelaide.edu.au)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.